News

Dover, Delaware — February 3, 2025 — AlphaLife Sciences, a global leader in generative AI-driven clinical development solutions, today announced the availability of AuroraPrime Create on Microsoft AppSource, an online cloud marketplace providing tailored line-of-business solutions.

AuroraPrime Create leverages advanced GenAI capabilities like prompt engineering, retrieval-augmented generation (RAG), and fine-tuning to enhance the entire lifecycle of medical and regulatory documentation. The product has proven to be a valuable tool in streamlining the creation of clinical study reports (CSRs), a key component of drug development that requires extensive cross-collaboration and attention to detail.

“We are excited to make AuroraPrime Create available on Microsoft AppSource, making it easier for pharmaceutical companies to access and implement our innovative GenAI solutions,” said Sharon Chen, CEO and founder of AlphaLife Sciences.

AuroraPrime Create was designed to elevate the creation of clinical documentation, tailored specifically for crafting essential clinical documentation like CSRs, SAPs, lay summaries, safety narratives, and study protocols. AuroraPrime Create enhances efficiency by automating first-draft creation and document lifecycle updates, and by supporting customizable templates for various therapeutic areas. It generates initial drafts within minutes, significantly accelerating documentation timelines and enabling faster collaborative review.

AuroraPrime Create offers powerful features designed to streamline clinical documentation. Its AI-driven document automation supports a wide range of clinical document types, while large-scale TFL automation enables efficient management and updating of data. Additionally, it provides automatic generation of TFL summaries based on the provided data.

Using AuroraPrime Create brings numerous benefits, including enhanced operational efficiency through streamlined processes and reduced authoring times. It also strengthens regulatory compliance and adherence to guidelines, lowers communication costs among study team members, boosts study transparency, and reduces the number of required reviews.

“Microsoft welcomes AuroraPrime Create to AppSource, where global customers find thousands of line-of-business partner solutions that work with the Microsoft products they already use,” said Giovanni Mezgec, Vice President, Modern Work + Business Applications Field & Partner Marketing, Microsoft Corp. “AppSource and trusted partners like AlphaLife Sciences help customers do more with less by increasing efficiency, buying confidently, and spending smarter.”

Learn more about AuroraPrime Create at its page on AppSource.

About AlphaLife Sciences

AlphaLife Sciences is a global leader in GenAI-driven clinical development solutions, advancing automated medical writing and regulatory documentation through its AuroraPrime platform. Backed up by the Microsoft for Startups Pegasus Program, Nvidia Inception Program, and Johnson & Johnson Innovation JLABS, AlphaLife Sciences is committed to reshaping drug development and expediting the delivery of life-saving treatments worldwide. For more information, visit https://alphalifesci.com.

Contact

Annie Chang  
annie.chang@alphalifesci.com